Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxandrolone
Drug ID BADD_D01634
Description A synthetic hormone with anabolic and androgenic properties.
Indications and Usage Use to promote weight gain after weight loss following extensive surgery.
Marketing Status approved; investigational
ATC Code A14AA08
DrugBank ID DB00621
KEGG ID D00462
MeSH ID D010074
PubChem ID 5878
TTD Drug ID D0U3GL
NDC Product Code 49884-301; 0245-0271; 0245-0272; 64181-0003; 63629-7603; 55486-1570; 62991-2699; 65129-1066; 51552-1579; 58159-046; 49884-302
UNII 7H6TM3CT4L
Synonyms Oxandrolone | Oxandrin | SC-11585 | SC 11585 | SC11585 | Anavar
Chemical Information
Molecular Formula C19H30O3
CAS Registry Number 53-39-4
SMILES CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hirsutism23.02.04.001; 05.05.01.005--
Insomnia19.02.01.002; 17.15.03.002--
Irritability19.04.02.013; 08.01.03.011--
Jaundice cholestatic09.01.01.005--Not Available
Menstruation irregular05.05.01.008; 21.01.01.005--
Necrosis24.04.02.006; 08.03.03.001--Not Available
Neoplasm16.16.02.001--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oligospermia21.03.03.005--
Peliosis hepatis09.01.07.010--Not Available
Penis disorder21.12.01.001--Not Available
Priapism24.04.12.007; 21.03.01.005--Not Available
Sodium retention14.05.04.003--Not Available
Testicular atrophy21.13.01.001; 05.05.02.004--Not Available
Testicular disorder21.13.01.002--
Virilism21.10.04.001; 05.05.01.001--
Virilism foetal21.10.04.002; 18.04.06.001; 05.05.01.009; 03.03.02.001--Not Available
Blood phosphorus increased13.11.01.016--Not Available
Drug tolerance08.06.01.003--Not Available
Haemorrhage24.07.01.002--Not Available
Blood alkaline phosphatase abnormal13.04.02.005--Not Available
Libido disorder21.03.02.006; 19.08.03.004--Not Available
Erectile dysfunction21.03.01.007; 19.08.04.001--
Bronchial hyperreactivity22.03.01.016--Not Available
Androgenetic alopecia23.02.02.002; 05.05.04.001--Not Available
The 2th Page    First    Pre   2    Total 2 Pages